Stocks and Investing Stocks and Investing
Tue, September 24, 2024
Mon, September 23, 2024

Tazeen Ahmad Maintained (ASND) at Strong Buy with Increased Target to $191 on, Sep 23rd, 2024


Published on 2024-10-28 14:24:54 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $175 to $191 on, Sep 23rd, 2024.

Tazeen has made no other calls on ASND in the last 4 months.



There are 10 other peers that have a rating on ASND. Out of the 10 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.



These are the ratings of the 10 analyists that currently disagree with Tazeen


  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $207 on, Tuesday, September 17th, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $289 on, Tuesday, September 17th, 2024
  • Josh Schimmer of "Evercore ISI Group" Maintained at Buy with Increased Target to $205 on, Tuesday, September 17th, 2024
  • Leland Gershell of "Oppenheimer" Reiterated at Buy with Increased Target to $190 on, Tuesday, September 17th, 2024
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $200 on, Tuesday, September 17th, 2024
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $170 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Strong Buy with Decreased Target to $157 on, Wednesday, September 4th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $165 on, Wednesday, September 4th, 2024
  • Kelly Shi of "Jefferies" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, August 13th, 2024
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
Contributing Sources